YKL-40 in serum: a promising biomarker of juvenile SLE and strongly correlated with disease duration.
Asmaa A AliRasha Nazih YoussefMai S ElsheikhAbeer R SalamahLiang L WuAlshaimaa R AlnaggarNoha M KhalilMervat E BehiryPublished in: Irish journal of medical science (2023)
YKL-40 in serum could be a promising biomarker in patients with SLE, especially in adolescent-onset cases. It is independently influenced by disease duration, anemia, thrombocytopenia, positive anti-dsDNA, and APL ab features.